Long-term Efficacy and Safety of Tacrolimus Plus Ustekinumab Combination Therapy in Children With Steroid-refractory Ulcerative Colitis

Inflamm Bowel Dis. 2024 Apr 3;30(4):686-687. doi: 10.1093/ibd/izae013.
No abstract available

Keywords: pediatric UC; steroid-refractory ulcerative colitis; tacrolimus; ustekinumab.

MeSH terms

  • Child
  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Remission Induction
  • Steroids
  • Tacrolimus* / adverse effects
  • Treatment Outcome
  • Ustekinumab / adverse effects

Substances

  • Tacrolimus
  • Ustekinumab
  • Immunosuppressive Agents
  • Steroids